CHM 11.1% 2.4¢ chimeric therapeutics limited

https://clinicaltrials.gov/study/NCT06055439A Phase 1/2 Study to...

  1. 737 Posts.
    lightbulb Created with Sketch. 523
    https://clinicaltrials.gov/study/NCT06055439

    A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy


    Not sure if this has been posted yet. It was last updated on the 28th of December

    I was just having a look into the Principal Investigator, a Dr Michael R Bishop, MD,University of Chicago. Extremely impressive individual.

    https://www.uchicagomedicine.org/find-a-physician/physician/michael-bishop

    Michael R. Bishop, MD, specializes in the diagnosis and treatment of lymphomas. In particular, he cares for patients with hematologic malignancies that have not responded to first-line treatments. An expert in hematopoietic stem cell transplantation (bone marrow transplantation) and cellular therapy, Dr. Bishop and his team are working to address the unique social, economic, physiological and biological issues that patients face while undergoing this treatment.

    Dr. Bishop's research focuses on the prevention and treatment of relapse after stem cell transplantation. Relapse is the primary cause of treatment failure and death after stem cell transplantation. He has served as the primary investigator on studies designed to prevent and treat disease recurrence after transplantation. Specifically, he works on ways to enhance immune effects of the transplanted cells against cancer.

    An active contributor to medical literature, Dr. Bishop has authored more than 150 peer-reviewed articles, in addition to more than 30 book chapters and two books on cancer treatment and research. He also serves on the editorial board of numerous scientific journals, including Biology of Blood and Marrow Transplantation.

    Dr. Bishop is a dedicated mentor, teaching residents and fellows in classroom, clinical and research settings. Many of his past trainees hold leadership roles in medical oncology and immunology at academic medical centers or at the National Cancer Institute in Bethesda, Maryland.

    Since 2001, Dr. Bishop has consistently been named one of the "Best Doctors in America" by Best Doctors, Inc. He previously served as a senior investigator and as the clinical head of stem cell transplantation for the National Cancer Institute at the National Institutes of Health.


    The video was from 4 years back.


    https://www.uchicagomedicine.org/find-a-clinical-trial?condition=CAR%20T-Cell%20Therapy&conditionId=dfd96fb9-d6f0-4538-bd63-6770086e6305&cat=clinicaltrial

    Looks like they have 8 Car T-cell Transplant Clinical trial's currently ongoing.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
-0.003(11.1%)
Mkt cap ! $20.55M
Open High Low Value Volume
2.7¢ 2.7¢ 2.3¢ $226.0K 9.449M

Buyers (Bids)

No. Vol. Price($)
3 2705742 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 600000 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
2.4¢
  Change
-0.003 ( 11.1 %)
Open High Low Volume
2.6¢ 2.6¢ 2.3¢ 4829989
Last updated 15.47pm 13/05/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.